NEO: NeoGenomics, Inc.
Performance
NEO +74.60%
Watchlist
Select an item
Summary
NEO at a glance
NEO returned +74.60% over the past year and -15.68% a year over five years. Its worst drop in that year was -45.61%, smaller than 29% of stocks on Redstone, and its Sharpe ratio of 1.24 beats 84% of stocks on Redstone. It pays no dividends.
Current Drawdown
-11.60%
Rolling Volatility
44.26%
Actions
Metrics
Risk Indicators
Alpha55.56%
Beta1.12x
Sharpe1.24
Sortino1.92
Omega1.23
Calmar1.64
Martin3.31
Profile
About NEO
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology.
- Sector
- Health Care
- Industry
- Services: Testing Laboratories
- Market cap
- $2.3B
- Listed
- Jan 1996
- Employees
- 2,500
- Headquarters
- Fort Myers, FL
- Website
- neogenomics.com
Comparisons